Tasmanian Botanics

What Tasmanian Botanics does

Tasmanian Botanics is an Australian medicinal cannabis manufacturer headquartered in Hobart, Tasmania. The company operates a vertically integrated production model that combines cannabis cultivation and AU-GMP (Australian Good Manufacturing Practice) manufacturing under a single roof in Tasmania's pristine environment, controlling the process from seed through post-harvest processing, primary packaging, and batch release. Its product offering centers on pharmaceutical-grade medicinal cannabis flower, marketed as pure, whole, and unadulterated, and the company self-describes as Australia's largest cultivator of medicinal cannabis. Distribution is exclusively through a network of four pharmaceutical and cannabis-industry channel partners (Canview, Aeris Health, Symbion, and The Entourage Effect), enabling pharmacies across Australia to order products through their existing accounts. End users are patients with valid prescriptions; prescribers (healthcare professionals) and dispensing pharmacies are the proximate B2B customers.

The business is privately held with no public financials, no disclosed funding rounds, no listed management team, and no disclosed revenue figures. The company holds a TGA-issued AU-GMP manufacturing licence covering plant inputs, process controls, cleaning, documentation, batch release, and change management under one integrated quality management system. Pricing is not publicly disclosed, and revenue mechanics rest on one-time product sales to pharmacies via distribution partners at confidential wholesale terms. The go-to-market motion is indirect-channel: physicians prescribe, pharmacies dispense, and channel partners handle logistics, with the company engaging healthcare professionals and prescribers as key stakeholders. The current operating posture is active, supported by a recent website footprint and ongoing distribution coverage, though a May 2026 phishing-related security incident was disclosed and contained without evidence of compromise to sensitive personal information.

Name

Tasmanian Botanics

Legal name

Tasmanian Botanics

Website

https://tasmanianbotanics.com.au

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Tasmanian Botanics is a privately held Australian manufacturer of pharmaceutical-grade medicinal cannabis, vertically integrating cultivation and AU-GMP manufacturing under one roof in Tasmania to supply pharmacies nationwide via four distribution partners.

Ownership category

akta.pro rank

Product category

Medicinal Cannabis Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

akta.pro secondary industry

Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)

Keywords

• Medicinal cannabis
• Cannabis cultivation
• Pharmaceutical cannabis manufacturing
• GMP manufacturing services
• Cannabis flower products

Headquarters

HQ city

Hobart

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medicinal Cannabis Products: Sale of cultivated and manufactured medicinal cannabis products to pharmacies through distribution partners across Australia.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels1 record

Core offering

Tasmanian Botanics cultivates and manufactures pharmaceutical-grade medicinal cannabis flower products in Tasmania under an AU-GMP licence issued by the TGA. Operations are vertically integrated from cultivation through post-harvest processing, primary packaging, and batch release. Finished products are sold to pharmacies across Australia through listed distribution partners.

Product overview

Tasmanian Botanics operates a vertically integrated medicinal cannabis business encompassing three core service pillars: cultivation services (growing cannabis in Tasmania's pristine environment), AU-GMP manufacturing (post-harvest processing, pharmaceutical-grade manufacturing, primary packaging, and batch release under TGA licence), and finished medicinal cannabis products (pharmaceutical-grade cannabis flower). The company controls every stage from seed to finished goods packaging, enabling full oversight of quality, consistency, and traceability across every batch. Their core product offering is naturally grown, pharmaceutical-grade medicinal cannabis intended for patient use across Australia.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Full traceability from seed to batch release
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core.

• CanviewcoreChannel Partner/ Reseller/ DistributorCanview serves as a distribution partner enabling pharmacies to order Tasmanian Botanics medicinal cannabis products. Pharmacies can register through Canview to access the products depending on their existing accounts and preferred suppliers.
• Aeris HealthcoreChannel Partner/ Reseller/ DistributorAeris Health provides pharmaceutical distribution services for Tasmanian Botanics products. Pharmacies can register directly through Aeris Health to place orders for medicinal cannabis products.
• SymbioncoreChannel Partner/ Reseller/ DistributorSymbion is a wholesale pharmaceutical distributor enabling pharmacies to access Tasmanian Botanics products. Pharmacies can order through Symbion's shop platform using their existing accounts.
• The Entourage EffectcoreChannel Partner/ Reseller/ DistributorThe Entourage Effect serves as a distribution partner for Tasmanian Botanics cannabis products. Pharmacies can register through this partner to gain access to ordering products.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Cann Group Limited: Australian medicinal cannabis cultivator and manufacturer with TGA-licensed cultivation and manufacturing operations; competes directly with Tasmanian Botanics in domestic medicinal flower supply to pharmacies.
• Little Green Pharma: Australian medicinal cannabis cultivator and manufacturer selling AU-GMP flower and oil products domestically and via export; comparable vertically integrated model with similar regulatory pathway.
• Althea Group Holdings: Australian medicinal cannabis producer with vertically integrated cultivation, manufacturing, and distribution to pharmacies; closest like-for-like competitor to Tasmanian Botanics in the domestic AU-GMP flower market.
• Medlab Clinical: Australian pharmaceutical company with a medicinal cannabis portfolio targeting prescribers and patients; comparable in channel strategy and TGA-driven product positioning.
• ANTG (Australian Natural Therapeutics Group): Australian medicinal cannabis cultivator and manufacturer with TGA-licensed production; comparable vertically integrated model focused on domestic AU-GMP flower supply.
• AusCann Group Holdings: Australian medicinal cannabis company focused on developing, producing, and supplying cannabinoid-based pharmaceutical products; competes in the same TGA-regulated domestic channel as Tasmanian Botanics.
• ECS Botanics Holdings: Australian medicinal cannabis cultivator and manufacturer producing AU-GMP flower for the Australian market; directly comparable in scale, format, and TGA-licensed positioning.

Broad incumbents

• Canopy Growth Corporation: Global cannabis producer with pharmaceutical-grade medicinal cannabis operations; relevant as a broad incumbent shaping global standards and competitive pricing benchmarks that Australian peers must match.
• Tilray Brands: Global cannabis cultivator and manufacturer with a broad medicinal and consumer portfolio; not directly competing in Tasmania but represents the international benchmark for scaled, GMP-certified cannabis production.

Emerging players

• BOD Australia: Australian medicinal cannabis and hemp-CBD company with cultivation and product development; overlaps with Tasmanian Botanics in the domestic medicinal and wellness channel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tasmanian-botanics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tasmanian Botanics